• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. Mar 1995; 95(3): 1225–1234.
PMCID: PMC441461

Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.


Detection of new ligand-defective mutations of apolipoprotein B (apoB) will enable identification of sequences involved in binding to the LDL receptor. Genomic DNA from patients attending a lipid clinic was screened by single-strand conformation polymorphism analysis for novel mutations in the putative LDL receptor-binding domain of apoB-100. A 46-yr-old woman of Celtic and Native American ancestry with primary hypercholesterolemia (total cholesterol [TC] 343 mg/dl; LDL cholesterol [LDL-C] 241 mg/dl) and pronounced peripheral vascular disease was found to be heterozygous for a novel Arg3531-->Cys mutation, caused by a C-->T transition at nucleotide 10800. One unrelated 59-yr-old man of Italian ancestry was found with the same mutation after screening 1,560 individuals. He had coronary heart disease, a TC of 310 mg/dl, and an LDL-C of 212 mg/dl. A total of eight individuals were found with the defect in the families of the two patients. They had an age- and sex-adjusted TC of 240 +/- 14 mg/dl and LDL-C of 169 +/- 10 mg/dl. This compares with eight unaffected family members with age- and sex-adjusted TC of 185 +/- 12 mg/dl and LDL-C of 124 +/- 12 mg/dl. In a dual-label fibroblast binding assay, LDL from the eight subjects with the mutation had an affinity for the LDL receptor that was 63% that of control LDL. LDL from eight unaffected family members had an affinity of 91%. By way of comparison, LDL from six patients heterozygous for the Arg3500-->Gln mutation had an affinity of 36%. The percentage mass ratio of the defective Cys3531 LDL to normal LDL was 59:41, as determined using the mAb MB19 and dynamic laser light scattering. Thus, the defective LDL had accumulated in the plasma of these patients. Using this mass ratio, it was calculated that the defective Cys3531 LDL particles bound with 27% of normal affinity. Deduced haplotypes using 10 apoB gene markers showed the Arg3531-->Cys alleles to be different in the two kindreds and indicates that the mutations arose independently. The Arg3531-->Cys mutation is the second reported cause of familial ligand-defective apoB.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Kontula K, Koivisto UM, Koivisto P, Turtola H. Molecular genetics of familial hypercholesterolaemia: common and rare mutations of the low density lipoprotein receptor gene. Ann Med. 1992 Oct;24(5):363–367. [PubMed]
  • Vega GL, Grundy SM. In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia. J Clin Invest. 1986 Nov;78(5):1410–1414. [PMC free article] [PubMed]
  • Innerarity TL, Weisgraber KH, Arnold KS, Mahley RW, Krauss RM, Vega GL, Grundy SM. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6919–6923. [PMC free article] [PubMed]
  • Soria LF, Ludwig EH, Clarke HR, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A. 1989 Jan;86(2):587–591. [PMC free article] [PubMed]
  • Weisgraber KH, Innerarity TL, Newhouse YM, Young SG, Arnold KS, Krauss RM, Vega GL, Grundy SM, Mahley RW. Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9758–9762. [PMC free article] [PubMed]
  • Myant NB, Gallagher JJ, Knight BL, McCarthy SN, Frostegård J, Nilsson J, Hamsten A, Talmud P, Humphries SE. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function. Arterioscler Thromb. 1991 May-Jun;11(3):691–703. [PubMed]
  • Corsini A, McCarthy BJ, Granata A, Soria LF, Fantappiè S, Bernini, Romano C, Romano L, Fumagalli R, Catapano AL. Familial defective apo B-100, characterization of an Italian family. Eur J Clin Invest. 1991 Aug;21(4):389–397. [PubMed]
  • Geisel J, Schleifenbaum T, Oette K, Weisshaar B. Familial defective apolipoprotein B-100 in 12 subjects and their kindred. Eur J Clin Chem Clin Biochem. 1992 Nov;30(11):729–736. [PubMed]
  • Rauh G, Keller C, Kormann B, Spengel F, Schuster H, Wolfram G, Zöllner N. Familial defective apolipoprotein B100: clinical characteristics of 54 cases. Atherosclerosis. 1992 Feb;92(2-3):233–241. [PubMed]
  • Bertolini S, Coviello DA, Masturzo P, Zucchetto E, Elicio N, Balestreri R, Orecchini G, Calandra S, Humphries S. RFLPs of the LDL-receptor gene: their use in the diagnosis of FH and in evaluation of different levels of gene expression on normal subjects. Eur J Epidemiol. 1992 May;8 (Suppl 1):18–25. [PubMed]
  • Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989 Nov;5(4):874–879. [PubMed]
  • Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2766–2770. [PMC free article] [PubMed]
  • Economou EP, Kazazian HH, Jr, Antonarakis SE. Detection of mutations in the factor VIII gene using single-stranded conformational polymorphism (SSCP). Genomics. 1992 Jul;13(3):909–911. [PubMed]
  • Plieth J, Rininsland F, Schlösser M, Cooper DN, Reiss J. Single-strand conformation polymorphism (SSCP) analysis of exon 11 of the CFTR gene reliably detects more than one third of non-delta F508 mutations in German cystic fibrosis patients. Hum Genet. 1992 Jan;88(3):283–287. [PubMed]
  • Zietkiewicz E, Sinnett D, Richer C, Mitchell G, Vanasse M, Labuda D. Single-strand conformational polymorphisms (SSCP): detection of useful polymorphisms at the dystrophin locus. Hum Genet. 1992 Jun;89(4):453–456. [PubMed]
  • Knott TJ, Pease RJ, Powell LM, Wallis SC, Rall SC, Jr, Innerarity TL, Blackhart B, Taylor WH, Marcel Y, Milne R, et al. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature. 1986 Oct 23;323(6090):734–738. [PubMed]
  • Yang CY, Chen SH, Gianturco SH, Bradley WA, Sparrow JT, Tanimura M, Li WH, Sparrow DA, DeLoof H, Rosseneu M, et al. Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Nature. 1986 Oct 23;323(6090):738–742. [PubMed]
  • Pease RJ, Milne RW, Jessup WK, Law A, Provost P, Fruchart JC, Dean RT, Marcel YL, Scott J. Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100. J Biol Chem. 1990 Jan 5;265(1):553–568. [PubMed]
  • Dunning AM, Houlston R, Frostegård J, Revill J, Nilsson J, Hamsten A, Talmud P, Humphries S. Genetic evidence that the putative receptor binding domain of apolipoprotein B (residues 3130 to 3630) is not the only region of the protein involved in interaction with the low density lipoprotein receptor. Biochim Biophys Acta. 1991 Apr 15;1096(3):231–237. [PubMed]
  • Fantappiè S, Corsini A, Sidoli A, Uboldi P, Granata A, Zanelli T, Rossi P, Marcovina S, Fumagalli R, Catapano AL. Monoclonal antibodies to human low density lipoprotein identify distinct areas on apolipoprotein B-100 relevant to the low density lipoprotein-receptor interaction. J Lipid Res. 1992 Aug;33(8):1111–1121. [PubMed]
  • Avoustin P, Mostachi H, Perret B, Cambou JP, Cambien F, de Préval C. A very conservative region of ApoB-100 in the putative binding region to the LDL receptor in the Toulouse population. Hum Genet. 1992 Dec;90(4):460–463. [PubMed]
  • Mendel CM. A novel assay for comparing affinity constants of ligands with small differences in affinity: application to low-density lipoproteins. Anal Biochem. 1994 Feb 1;216(2):328–334. [PubMed]
  • Bell GI, Karam JH, Rutter WJ. Polymorphic DNA region adjacent to the 5' end of the human insulin gene. Proc Natl Acad Sci U S A. 1981 Sep;78(9):5759–5763. [PMC free article] [PubMed]
  • Pullinger CR, Hillas E, Hardman DA, Chen GC, Naya-Vigne JM, Iwasa JA, Hamilton RL, Lalouel JM, Williams RR, Kane JP. Two apolipoprotein B gene defects in a kindred with hypobetalipoproteinemia, one of which results in a truncated variant, apoB-61, in VLDL and LDL. J Lipid Res. 1992 May;33(5):699–710. [PubMed]
  • Pullinger CR, Zysow BR, Hennessy LK, Frost PH, Malloy MJ, Kane JP. Molecular cloning and characteristics of a new apolipoprotein C-II mutant identified in three unrelated individuals with hypercholesterolemia and hypertriglyceridemia. Hum Mol Genet. 1993 Jan;2(1):69–74. [PubMed]
  • Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1972 Feb 21;260(2):212–221. [PubMed]
  • Young SG, Bertics SJ, Curtiss LK, Casal DC, Witztum JL. Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B. Proc Natl Acad Sci U S A. 1986 Feb;83(4):1101–1105. [PMC free article] [PubMed]
  • Ma YH, Wang XB, Bütler R, Schumaker VN. Bsp 12861 restriction fragment length polymorphism detects Ag(c/g) locus of human apolipoprotein B in all 17 persons studied. Arteriosclerosis. 1989 Mar-Apr;9(2):242–246. [PubMed]
  • Young SG, Hubl ST. An ApaLI restriction site polymorphism is associated with the MB19 polymorphism in apolipoprotein B. J Lipid Res. 1989 Mar;30(3):443–449. [PubMed]
  • Ludwig EH, McCarthy BJ. Haplotype analysis of the human apolipoprotein B mutation associated with familial defective apolipoprotein B100. Am J Hum Genet. 1990 Oct;47(4):712–720. [PMC free article] [PubMed]
  • Wang XB, Schlapfer P, Ma YH, Bütler R, Elovson J, Schumaker VN. Apolipoprotein B: the Ag(a1/d) immunogenetic polymorphism coincides with a T-to-C substitution at nucleotide 1981, creating an Alu I restriction site. Arteriosclerosis. 1988 Jul-Aug;8(4):429–435. [PubMed]
  • Wu MJ, Bütler E, Bütler R, Schumaker VN. Identification of the base substitution responsible for the Ag(x/y) polymorphism of apolipoprotein B-100. Arterioscler Thromb. 1991 Mar-Apr;11(2):379–384. [PubMed]
  • Warnich L, Kotze MJ, Langenhoven E, Retief AE. Detection of a frequent polymorphism in exon 10 of the low-density lipoprotein receptor gene. Hum Genet. 1992 May;89(3):362–362. [PubMed]
  • Leitersdorf E, Hobbs HH. Human LDL receptor gene: HincII polymorphism detected by gene amplification. Nucleic Acids Res. 1988 Jul 25;16(14B):7215–7215. [PMC free article] [PubMed]
  • Cavanaugh JA, Easteal S. A HaeIII polymorphism in the 3' untranslated region of the low density lipoprotein receptor (LDLR) gene. Nucleic Acids Res. 1991 Dec 11;19(23):6663–6663. [PMC free article] [PubMed]
  • Kotze MJ, Langenhoven E, Dietzsch E, Retief AE. A RFLP associated with the low-density lipoprotein receptor gene (LDLR). Nucleic Acids Res. 1987 Jan 12;15(1):376–376. [PMC free article] [PubMed]
  • Zuliani G, Hobbs HH. Dinucleotide repeat polymorphism at the 3' end of the LDL receptor gene. Nucleic Acids Res. 1990 Jul 25;18(14):4300–4300. [PMC free article] [PubMed]
  • Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990 Mar;31(3):545–548. [PubMed]
  • Pagnan A, Havel RJ, Kane JP, Kotite L. Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia. J Lipid Res. 1977 Sep;18(5):613–622. [PubMed]
  • Friedl W, Ludwig EH, Balestra ME, Arnold KS, Paulweber B, Sandhofer F, McCarthy BJ, Innerarity TL. Apolipoprotein B gene mutations in Austrian subjects with heart disease and their kindred. Arterioscler Thromb. 1991 Mar-Apr;11(2):371–378. [PubMed]
  • Innerarity TL, Mahley RW, Weisgraber KH, Bersot TP, Krauss RM, Vega GL, Grundy SM, Friedl W, Davignon J, McCarthy BJ. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res. 1990 Aug;31(8):1337–1349. [PubMed]
  • Lund-Katz S, Innerarity TL, Arnold KS, Curtiss LK, Phillips MC. 13C NMR evidence that substitution of glutamine for arginine 3500 in familial defective apolipoprotein B-100 disrupts the conformation of the receptor-binding domain. J Biol Chem. 1991 Feb 15;266(5):2701–2704. [PubMed]
  • Rauh G, Schuster H, Fischer J, Keller C, Wolfram G, Zöllner N. Familial defective apolipoprotein B-100: haplotype analysis of the arginine(3500)----glutamine mutation. Atherosclerosis. 1991 Jun;88(2-3):219–226. [PubMed]
  • Rauh G, Schuster H, Schewe CK, Stratmann G, Keller C, Wolfram G, Zöllner N. Independent mutation of arginine(3500)-->glutamine associated with familial defective apolipoprotein B-100. J Lipid Res. 1993 May;34(5):799–805. [PubMed]
  • Bersot TP, Russell SJ, Thatcher SR, Pomernacki NK, Mahley RW, Weisgraber KH, Innerarity TL, Fox CS. A unique haplotype of the apolipoprotein B-100 allele associated with familial defective apolipoprotein B-100 in a Chinese man discovered during a study of the prevalence of this disorder. J Lipid Res. 1993 Jul;34(7):1149–1154. [PubMed]
  • Youssoufian H, Antonarakis SE, Bell W, Griffin AM, Kazazian HH., Jr Nonsense and missense mutations in hemophilia A: estimate of the relative mutation rate at CG dinucleotides. Am J Hum Genet. 1988 May;42(5):718–725. [PMC free article] [PubMed]
  • Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res. 1991 Nov;32(11):1741–1753. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem Compound links
  • Gene
    Gene links
  • GEO Profiles
    GEO Profiles
    Related GEO records
  • HomoloGene
    HomoloGene links
  • MedGen
    Related information in MedGen
  • OMIM
    OMIM record citing PubMed
  • Protein
    Published protein sequences
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...